0001493152-17-012342.txt : 20171102 0001493152-17-012342.hdr.sgml : 20171102 20171102160905 ACCESSION NUMBER: 0001493152-17-012342 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171102 DATE AS OF CHANGE: 20171102 EFFECTIVENESS DATE: 20171102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ONCOSEC MEDICAL Inc CENTRAL INDEX KEY: 0001444307 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980573252 STATE OF INCORPORATION: NV FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-298011 FILM NUMBER: 171172393 BUSINESS ADDRESS: STREET 1: 5820 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 210-7333 MAIL ADDRESS: STREET 1: 5820 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: NetVentory Solutions, Inc. DATE OF NAME CHANGE: 20080902 D 1 primary_doc.xml X0708 D LIVE 0001444307 ONCOSEC MEDICAL Inc 5820 NANCY RIDGE DRIVE SAN DIEGO CA CALIFORNIA 92121 855-662-6732 NEVADA None NetVentory Solutions, Inc. Corporation true Punit Dhillon 5820 Nancy Ridge Drive San Diego CA CALIFORNIA 92121 Executive Officer Director Avtar Dhillon 5820 Nancy Ridge Drive San Diego CA CALIFORNIA 92121 Director James DeMesa 5820 Nancy Ridge Drive San Diego CA CALIFORNIA 92121 Director Anthony Maida 5820 Nancy Ridge Drive San Diego CA CALIFORNIA 92121 Director Annalisa Jenkins 5820 Nancy Ridge Drive San Diego CA CALIFORNIA 92121 Director Daniel O'Connor 5820 Nancy Ridge Drive San Diego CA CALIFORNIA 92121 Director Richard Slansky 5820 Nancy Ridge Drive San Diego CA CALIFORNIA 92121 Executive Officer Biotechnology Decline to Disclose 06b false 2017-10-25 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE 4TH FLOOR NEW YORK NY NEW YORK 10022 IL ILLINOIS NJ NEW JERSEY NY NEW YORK TX TEXAS false 4941500 4941500 0 Represents aggregate exercise price for warrants covered by this Form D. The warrants were issued in a private placement conducted concurrently with a registered direct offering of shares of the Issuer's common stock, which are not covered by this Form D. false 9 389555 0 The Issuer also reimbursed H.C. Wainwright $50,000 in expenses and granted its designees warrants to purchase a total of 316,256 shares of common stock with an exercise price of $1.68 per share as compensation for certain placement agent services. 0 Any proceeds from the private placement will be used for working capital and general corporate purposes, which could include payments of salaries or other compensation to the Issuer's executive officers or directors. false ONCOSEC MEDICAL Inc /s/ Punit S. Dhillon Punit S. Dhillon President & Chief Executive Officer 2017-11-02